Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-25 @ 2:31 PM
NCT ID:
NCT00686166
Group ID:
EG001
Title:
Chemotherapy + Radiation
Description:
Patients receive oxaliplatin 50 mg/m\^2 IV (Days 50, 57, 71, 78), cetuximab 250 mg/m\^2 IV (Days 50, 57, 64, 71, 78), capecitabine 1650 mg/m\^2 PO (Monday-Friday, Day 50-84). Radiation therapy begins on Day 50. Dose and length of treatment are dependent on technique used and clinical stage. Planned target value 1: 4500 cGy (centigray) in 25 fractions; Planned target value 2 (stage 3 patients): Boost of 540 cGy in 3 fractions; Planning target value 2 (stage T4 patients): Boost of 900 cGy in 5 fractions.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
68
Other Number Affected:
66
Other Number At Risk:
68
Study:
NCT00686166
Results Section:
NCT00686166
Adverse Events Module:
NCT00686166